FTHFX
Price
$58.72
Change
+$0.60 (+1.03%)
Updated
Sep 11 closing price
Net Assets
12.15B
KESGX
Price
$19.72
Change
+$0.19 (+0.97%)
Updated
Sep 11 closing price
Net Assets
89.8M
Interact to see
Advertisement

FTHFX vs KESGX

FTHFX vs KESGX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. KESGX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and KESGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 12.1B vs. KESGX (89.8M). FTHFX pays higher dividends than KESGX: FTHFX (0.56) vs KESGX (0.22). FTHFX was incepted earlier than KESGX: FTHFX (15 years) vs KESGX (7 years). KESGX (1.08) is less costly to investors than FTHFX (0.64). KESGX is a more actively managed with annual turnover of: 57.00 vs. FTHFX (28.00). KESGX has a lower initial minimum investment than FTHFX: KESGX (5000) vs FTHFX (1000000). FTHFX annual gain was more profitable for investors over the last year : 15.30 vs. KESGX (11.63). FTHFX return over 5 years is better than : 60.92 vs. KESGX (26.46).
FTHFXKESGXFTHFX / KESGX
Total Expense Ratio0.640.8278%
Annual Report Gross Expense Ratio0.641.0859%
Fund Existence15 years7 years-
Gain YTD14.83917.29786%
Front LoadN/AN/A-
Min. Initial Investment1000000500020,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B89.8M13,474%
Annual Yield % from dividends0.560.22258%
Returns for 1 year15.3011.63132%
Returns for 3 years58.6846.07127%
Returns for 5 years60.9226.46230%
Returns for 10 years237.29N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHIX45.99N/A
N/A
Hartford Healthcare I
PLBEX35.20N/A
N/A
Plumb Equity Investor
GAOZX21.91N/A
N/A
JPMorgan Global Allocation R6
FIAOX33.64N/A
N/A
Fidelity Advisor® Equity Dividend Inc A
MYIIX11.94-0.03
-0.25%
NYLIM WMC International Research Eq Cl I